Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chest Pain | 25 | 2020 | 205 | 5.560 |
Why?
|
| Emergency Service, Hospital | 27 | 2020 | 444 | 3.670 |
Why?
|
| Acute Coronary Syndrome | 18 | 2020 | 167 | 3.430 |
Why?
|
| Myocardial Infarction | 18 | 2020 | 466 | 1.990 |
Why?
|
| Patient Discharge | 7 | 2019 | 204 | 1.410 |
Why?
|
| Cardiology Service, Hospital | 3 | 2015 | 19 | 1.210 |
Why?
|
| Risk Assessment | 16 | 2020 | 1423 | 1.150 |
Why?
|
| Electrocardiography | 16 | 2020 | 624 | 1.110 |
Why?
|
| Coronary Angiography | 8 | 2018 | 159 | 1.080 |
Why?
|
| Exercise Test | 5 | 2019 | 218 | 0.940 |
Why?
|
| Troponin | 10 | 2020 | 101 | 0.930 |
Why?
|
| Middle Aged | 39 | 2020 | 11840 | 0.920 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2013 | 1212 | 0.770 |
Why?
|
| Coronary Artery Disease | 3 | 2018 | 427 | 0.760 |
Why?
|
| Male | 42 | 2020 | 19438 | 0.740 |
Why?
|
| Female | 42 | 2020 | 19945 | 0.740 |
Why?
|
| Aged | 29 | 2020 | 10250 | 0.720 |
Why?
|
| Length of Stay | 5 | 2015 | 321 | 0.690 |
Why?
|
| Decision Support Techniques | 4 | 2020 | 130 | 0.660 |
Why?
|
| Inpatients | 3 | 2011 | 83 | 0.640 |
Why?
|
| Humans | 49 | 2020 | 32273 | 0.630 |
Why?
|
| Predictive Value of Tests | 11 | 2020 | 880 | 0.610 |
Why?
|
| Angina Pectoris | 2 | 2013 | 20 | 0.610 |
Why?
|
| Adult | 25 | 2020 | 9261 | 0.580 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 48 | 0.540 |
Why?
|
| Hospitalization | 7 | 2020 | 475 | 0.520 |
Why?
|
| Logistic Models | 9 | 2020 | 743 | 0.520 |
Why?
|
| Troponin C | 1 | 2017 | 8 | 0.500 |
Why?
|
| Observation | 2 | 2013 | 22 | 0.490 |
Why?
|
| Anticoagulants | 4 | 2011 | 122 | 0.480 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2017 | 904 | 0.480 |
Why?
|
| Critical Pathways | 4 | 2018 | 47 | 0.470 |
Why?
|
| Emergency Medicine | 2 | 2008 | 110 | 0.460 |
Why?
|
| Odds Ratio | 6 | 2020 | 455 | 0.440 |
Why?
|
| Retrospective Studies | 11 | 2019 | 3609 | 0.440 |
Why?
|
| North Carolina | 8 | 2020 | 1300 | 0.430 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2008 | 79 | 0.390 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 62 | 0.380 |
Why?
|
| Emergency Treatment | 1 | 2013 | 37 | 0.380 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2012 | 12 | 0.370 |
Why?
|
| Heart Diseases | 2 | 2011 | 114 | 0.370 |
Why?
|
| Triage | 2 | 2010 | 68 | 0.370 |
Why?
|
| Risk Factors | 9 | 2020 | 3933 | 0.350 |
Why?
|
| Coronary Vessels | 1 | 2013 | 174 | 0.350 |
Why?
|
| Time Factors | 8 | 2020 | 2203 | 0.350 |
Why?
|
| Myocardial Revascularization | 3 | 2018 | 34 | 0.350 |
Why?
|
| Prospective Studies | 10 | 2020 | 2316 | 0.340 |
Why?
|
| Health Expenditures | 1 | 2011 | 66 | 0.340 |
Why?
|
| Hospital Costs | 1 | 2011 | 48 | 0.340 |
Why?
|
| Coronary Stenosis | 1 | 2011 | 28 | 0.340 |
Why?
|
| Patient Admission | 1 | 2011 | 54 | 0.330 |
Why?
|
| Fibrinolytic Agents | 2 | 2008 | 63 | 0.330 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2007 | 59 | 0.320 |
Why?
|
| Registries | 7 | 2015 | 294 | 0.320 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 501 | 0.310 |
Why?
|
| Health Services | 1 | 2010 | 40 | 0.300 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 167 | 0.300 |
Why?
|
| Peptide Fragments | 2 | 2009 | 415 | 0.300 |
Why?
|
| Pulmonary Embolism | 4 | 2011 | 51 | 0.300 |
Why?
|
| Research Support as Topic | 1 | 2008 | 32 | 0.280 |
Why?
|
| United States | 12 | 2020 | 4069 | 0.270 |
Why?
|
| Acute Disease | 8 | 2020 | 253 | 0.270 |
Why?
|
| Cohort Studies | 8 | 2018 | 1840 | 0.270 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 12 | 0.260 |
Why?
|
| Reproducibility of Results | 6 | 2017 | 756 | 0.260 |
Why?
|
| Severity of Illness Index | 8 | 2018 | 854 | 0.260 |
Why?
|
| Biomedical Research | 1 | 2008 | 178 | 0.240 |
Why?
|
| Prognosis | 4 | 2015 | 1529 | 0.230 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2005 | 101 | 0.220 |
Why?
|
| Myocardial Ischemia | 2 | 2008 | 98 | 0.220 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 135 | 0.210 |
Why?
|
| Occupational Exposure | 1 | 2016 | 159 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 197 | 0.200 |
Why?
|
| Craniocerebral Trauma | 2 | 2015 | 55 | 0.200 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2008 | 34 | 0.200 |
Why?
|
| Decision Making | 3 | 2016 | 190 | 0.200 |
Why?
|
| Coronary Disease | 1 | 2005 | 226 | 0.200 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.200 |
Why?
|
| Hispanic Americans | 2 | 2020 | 772 | 0.200 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 2238 | 0.190 |
Why?
|
| Emergency Medical Services | 2 | 2018 | 183 | 0.190 |
Why?
|
| Heart Failure | 5 | 2010 | 728 | 0.190 |
Why?
|
| Age Factors | 4 | 2018 | 1178 | 0.180 |
Why?
|
| Comorbidity | 3 | 2009 | 563 | 0.170 |
Why?
|
| Aged, 80 and over | 7 | 2013 | 3893 | 0.170 |
Why?
|
| Patient Readmission | 2 | 2013 | 135 | 0.160 |
Why?
|
| Mortality | 1 | 2020 | 122 | 0.150 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 556 | 0.150 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 110 | 0.150 |
Why?
|
| Pain Measurement | 2 | 2019 | 339 | 0.150 |
Why?
|
| Hemorrhage | 3 | 2015 | 95 | 0.150 |
Why?
|
| Enoxaparin | 2 | 2009 | 13 | 0.140 |
Why?
|
| Clinical Trials as Topic | 3 | 2010 | 312 | 0.140 |
Why?
|
| Heparin | 2 | 2009 | 65 | 0.140 |
Why?
|
| Ethnic Groups | 1 | 2020 | 450 | 0.140 |
Why?
|
| Hospital Mortality | 3 | 2009 | 197 | 0.130 |
Why?
|
| Troponin T | 1 | 2018 | 92 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 89 | 0.110 |
Why?
|
| Incidence | 3 | 2016 | 1242 | 0.110 |
Why?
|
| Algorithms | 1 | 2018 | 536 | 0.110 |
Why?
|
| Death | 1 | 2015 | 51 | 0.110 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 23 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2015 | 77 | 0.110 |
Why?
|
| Hypotension | 1 | 2015 | 43 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 44 | 0.110 |
Why?
|
| Confidence Intervals | 2 | 2011 | 141 | 0.100 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2010 | 22 | 0.100 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 16 | 0.100 |
Why?
|
| Shock | 1 | 2013 | 34 | 0.100 |
Why?
|
| Sex Factors | 3 | 2020 | 656 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 1159 | 0.090 |
Why?
|
| Hirudins | 2 | 2009 | 11 | 0.090 |
Why?
|
| Forecasting | 2 | 2010 | 144 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2009 | 3408 | 0.090 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 161 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 98 | 0.090 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 26 | 0.090 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 264 | 0.090 |
Why?
|
| Coronary Care Units | 1 | 2011 | 6 | 0.090 |
Why?
|
| Models, Economic | 1 | 2011 | 18 | 0.090 |
Why?
|
| Tomography, X-Ray | 1 | 2011 | 5 | 0.090 |
Why?
|
| Cost Savings | 1 | 2011 | 34 | 0.090 |
Why?
|
| Drug Costs | 1 | 2011 | 46 | 0.080 |
Why?
|
| Adenosine | 1 | 2011 | 68 | 0.080 |
Why?
|
| Dobutamine | 1 | 2011 | 54 | 0.080 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 772 | 0.080 |
Why?
|
| Echocardiography | 1 | 2011 | 190 | 0.080 |
Why?
|
| Myocardium | 1 | 2011 | 184 | 0.080 |
Why?
|
| Heart | 1 | 2011 | 177 | 0.080 |
Why?
|
| Linear Models | 1 | 2011 | 426 | 0.080 |
Why?
|
| Medical Audit | 1 | 2010 | 15 | 0.080 |
Why?
|
| Carbon Dioxide | 1 | 2010 | 35 | 0.080 |
Why?
|
| Costs and Cost Analysis | 1 | 2010 | 106 | 0.080 |
Why?
|
| Safety Management | 1 | 2010 | 27 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2009 | 38 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2010 | 29 | 0.080 |
Why?
|
| Oxygen | 1 | 2010 | 138 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2010 | 171 | 0.070 |
Why?
|
| Information Services | 1 | 2009 | 11 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2009 | 86 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 287 | 0.070 |
Why?
|
| Coronary Thrombosis | 1 | 2008 | 12 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2008 | 31 | 0.070 |
Why?
|
| Dyspnea | 1 | 2008 | 32 | 0.070 |
Why?
|
| Ticlopidine | 1 | 2008 | 12 | 0.070 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 14 | 0.070 |
Why?
|
| Tyrosine | 1 | 2008 | 24 | 0.070 |
Why?
|
| Pyridines | 1 | 2008 | 79 | 0.070 |
Why?
|
| Aspirin | 1 | 2008 | 59 | 0.070 |
Why?
|
| Heart Conduction System | 1 | 2008 | 76 | 0.070 |
Why?
|
| Continuity of Patient Care | 1 | 2008 | 73 | 0.070 |
Why?
|
| Patient Selection | 2 | 2008 | 272 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 1480 | 0.060 |
Why?
|
| Peptides | 1 | 2008 | 127 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2007 | 62 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2007 | 109 | 0.060 |
Why?
|
| Cause of Death | 1 | 2007 | 236 | 0.060 |
Why?
|
| Coronary Artery Bypass | 1 | 2007 | 100 | 0.060 |
Why?
|
| Research Design | 1 | 2008 | 316 | 0.060 |
Why?
|
| Recurrence | 1 | 2007 | 286 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 245 | 0.060 |
Why?
|
| Singapore | 1 | 2005 | 7 | 0.060 |
Why?
|
| Survival Rate | 2 | 2018 | 892 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 38 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 395 | 0.050 |
Why?
|
| Adolescent | 4 | 2015 | 3516 | 0.050 |
Why?
|
| Injury Severity Score | 2 | 2015 | 110 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2016 | 854 | 0.050 |
Why?
|
| Prevalence | 1 | 2005 | 955 | 0.050 |
Why?
|
| Infant | 2 | 2015 | 1010 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2015 | 1233 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 44 | 0.040 |
Why?
|
| Child | 2 | 2015 | 2431 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2020 | 1076 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 26 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2015 | 84 | 0.030 |
Why?
|
| African Americans | 1 | 2020 | 1335 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2015 | 666 | 0.020 |
Why?
|
| Age Distribution | 1 | 2013 | 194 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 241 | 0.020 |
Why?
|
| Nitroglycerin | 1 | 2010 | 10 | 0.020 |
Why?
|
| Exhalation | 1 | 2010 | 3 | 0.020 |
Why?
|
| Capnography | 1 | 2010 | 7 | 0.020 |
Why?
|
| Tomography, Spiral Computed | 1 | 2010 | 19 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2010 | 40 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2009 | 21 | 0.020 |
Why?
|
| Observer Variation | 1 | 2009 | 96 | 0.020 |
Why?
|
| ROC Curve | 1 | 2010 | 169 | 0.020 |
Why?
|
| Disease Management | 1 | 2010 | 129 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 66 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 128 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2007 | 650 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 551 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 476 | 0.010 |
Why?
|
| Cardiology | 1 | 2005 | 104 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 2651 | 0.010 |
Why?
|